Logo image of UCL

UCLOUDLINK GROUP INC (UCL) Stock Fundamental Analysis

NASDAQ:UCL - Nasdaq - US90354D1046 - ADR - Currency: USD

1.83  0 (0%)

Fundamental Rating

4

Taking everything into account, UCL scores 4 out of 10 in our fundamental rating. UCL was compared to 21 industry peers in the Wireless Telecommunication Services industry. UCL has an average financial health and profitability rating. UCL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year UCL was profitable.
In the past year UCL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: UCL reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: UCL reported negative operating cash flow in multiple years.
UCL Yearly Net Income VS EBIT VS OCF VS FCFUCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

With an excellent Return On Assets value of 5.60%, UCL belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
UCL's Return On Equity of 16.48% is amongst the best of the industry. UCL outperforms 80.95% of its industry peers.
UCL's Return On Invested Capital of 8.96% is fine compared to the rest of the industry. UCL outperforms 71.43% of its industry peers.
Industry RankSector Rank
ROA 5.6%
ROE 16.48%
ROIC 8.96%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
UCL Yearly ROA, ROE, ROICUCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

UCL has a Profit Margin (3.81%) which is comparable to the rest of the industry.
UCL's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 3.69%, UCL is in line with its industry, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Operating Margin of UCL has declined.
UCL has a worse Gross Margin (47.75%) than 61.90% of its industry peers.
In the last couple of years the Gross Margin of UCL has grown nicely.
Industry RankSector Rank
OM 3.69%
PM (TTM) 3.81%
GM 47.75%
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
UCL Yearly Profit, Operating, Gross MarginsUCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UCL is still creating some value.
Compared to 1 year ago, UCL has more shares outstanding
The number of shares outstanding for UCL has been increased compared to 5 years ago.
Compared to 1 year ago, UCL has a worse debt to assets ratio.
UCL Yearly Shares OutstandingUCL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
UCL Yearly Total Debt VS Total AssetsUCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -2.06, we must say that UCL is in the distress zone and has some risk of bankruptcy.
UCL's Altman-Z score of -2.06 is on the low side compared to the rest of the industry. UCL is outperformed by 90.48% of its industry peers.
The Debt to FCF ratio of UCL is 1.06, which is an excellent value as it means it would take UCL, only 1.06 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of UCL (1.06) is better than 95.24% of its industry peers.
UCL has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
UCL has a Debt to Equity ratio of 0.37. This is amongst the best in the industry. UCL outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.06
Altman-Z -2.06
ROIC/WACC1.06
WACC8.46%
UCL Yearly LT Debt VS Equity VS FCFUCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.34 indicates that UCL should not have too much problems paying its short term obligations.
UCL's Current ratio of 1.34 is fine compared to the rest of the industry. UCL outperforms 61.90% of its industry peers.
A Quick Ratio of 1.28 indicates that UCL should not have too much problems paying its short term obligations.
UCL's Quick ratio of 1.28 is fine compared to the rest of the industry. UCL outperforms 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.28
UCL Yearly Current Assets VS Current LiabilitesUCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 200.00% over the past year.
UCL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.89% yearly.
The Revenue has been growing slightly by 7.65% in the past year.
UCL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.37% yearly.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-300%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%3.43%

3.2 Future

Based on estimates for the next years, UCL will show a very negative growth in Earnings Per Share. The EPS will decrease by -49.75% on average per year.
UCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.48% yearly.
EPS Next Y-91.58%
EPS Next 2Y-49.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.96%
Revenue Next 2Y6.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
UCL Yearly Revenue VS EstimatesUCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
UCL Yearly EPS VS EstimatesUCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.33, UCL is valued on the expensive side.
61.90% of the companies in the same industry are more expensive than UCL, based on the Price/Earnings ratio.
UCL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 60.40, the valuation of UCL can be described as expensive.
80.95% of the companies in the same industry are cheaper than UCL, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of UCL to the average of the S&P500 Index (21.74), we can say UCL is valued expensively.
Industry RankSector Rank
PE 20.33
Fwd PE 60.4
UCL Price Earnings VS Forward Price EarningsUCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UCL indicates a rather cheap valuation: UCL is cheaper than 85.71% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UCL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 9.2
EV/EBITDA 3.81
UCL Per share dataUCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

UCL's earnings are expected to decrease with -49.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)5.23
EPS Next 2Y-49.75%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for UCL!.
Industry RankSector Rank
Dividend Yield N/A

UCLOUDLINK GROUP INC

NASDAQ:UCL (7/7/2025, 8:00:02 PM)

1.83

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners17.57%
Inst Owner Change0%
Ins Owners8.51%
Ins Owner ChangeN/A
Market Cap68.87M
Analysts80
Price Target9.18 (401.64%)
Short Float %0.48%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-320.79%
Min EPS beat(2)-692.08%
Max EPS beat(2)50.5%
EPS beat(4)3
Avg EPS beat(4)-61.88%
Min EPS beat(4)-692.08%
Max EPS beat(4)296.04%
EPS beat(8)5
Avg EPS beat(8)-31.19%
EPS beat(12)7
Avg EPS beat(12)-6.79%
EPS beat(16)9
Avg EPS beat(16)-86.94%
Revenue beat(2)2
Avg Revenue beat(2)2.1%
Min Revenue beat(2)2%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-4.25%
Max Revenue beat(4)2.2%
Revenue beat(8)5
Avg Revenue beat(8)-1.13%
Revenue beat(12)6
Avg Revenue beat(12)-1.13%
Revenue beat(16)8
Avg Revenue beat(16)-0.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)100%
EPS NY rev (1m)116.67%
EPS NY rev (3m)116.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.1%
Valuation
Industry RankSector Rank
PE 20.33
Fwd PE 60.4
P/S 0.75
P/FCF 9.2
P/OCF 9.2
P/B 3.23
P/tB 3.3
EV/EBITDA 3.81
EPS(TTM)0.09
EY4.92%
EPS(NY)0.03
Fwd EY1.66%
FCF(TTM)0.2
FCFY10.87%
OCF(TTM)0.2
OCFY10.87%
SpS2.45
BVpS0.57
TBVpS0.55
PEG (NY)N/A
PEG (5Y)5.23
Profitability
Industry RankSector Rank
ROA 5.6%
ROE 16.48%
ROCE 15.43%
ROIC 8.96%
ROICexc N/A
ROICexgc N/A
OM 3.69%
PM (TTM) 3.81%
GM 47.75%
FCFM 8.11%
ROA(3y)-10.45%
ROA(5y)-33.28%
ROE(3y)-58.54%
ROE(5y)-103.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-2.15%
PM growth 3YN/A
PM growth 5Y26.84%
GM growth 3Y17.9%
GM growth 5Y3.39%
F-Score6
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.06
Debt/EBITDA 1.39
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 130.59%
Profit Quality 212.95%
Current Ratio 1.34
Quick Ratio 1.28
Altman-Z -2.06
F-Score6
WACC8.46%
ROIC/WACC1.06
Cap/Depr(3y)133.27%
Cap/Depr(5y)103.42%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5Y3.89%
EPS Q2Q%-300%
EPS Next Y-91.58%
EPS Next 2Y-49.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.65%
Revenue growth 3Y7.48%
Revenue growth 5Y-10.37%
Sales Q2Q%3.43%
Revenue Next Year5.96%
Revenue Next 2Y6.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y229.65%
EBIT growth 3YN/A
EBIT growth 5Y-12.3%
EBIT Next Year25.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.6%
FCF growth 3YN/A
FCF growth 5Y12.11%
OCF growth 1Y-28.6%
OCF growth 3YN/A
OCF growth 5Y9.78%